Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cubist Pharmaceuticals
Cubist Pharmaceuticals
Sector Snap: Specialty drugs in 2012
BusinessWeek
Sun, 01/8/12 - 12:58 pm
Salix
Cubist Pharmaceuticals
Ironwood Pharmaceuticals
Emergent BioSolutions
Xifaxin
Cubicin
Alkermes
Questcor Pharmaceuticals
Cubist Pharmaceuticals Completes Acquisition of Adolor Corporation
Yahoo
Mon, 12/12/11 - 10:42 am
Cubist Pharmaceuticals
Adolor
M&A
Cubist Pharmaceuticals to Acquire Adolor for $190 Million
Bloomberg
Mon, 10/24/11 - 11:05 am
Adolor
M&A
Cubist Pharmaceuticals
This Week in Biotech
Motley Fool
Sat, 10/1/11 - 01:51 pm
Pharmasset
GSK
Human Genome Sciences
Vertex Pharmaceuticals
Optimer Pharmaceuticals
Cubist Pharmaceuticals
Array Biopharma
AstraZeneca
Neglected Bacteria Give Cubist $2B Market
Bloomberg
Thu, 09/15/11 - 09:40 am
antibiotics
Cubist Pharmaceuticals
CXA-201
gram negative bacterial infections
Drug Launches: It's All About Expectations
Motley Fool
Wed, 09/14/11 - 11:00 am
drug launches
Optimer
Dificid
Dendreon
Provenge
Vancocin
ViroPharma
Cubist Pharmaceuticals
1 Reason the Street Should Expect Big Things From ViroPharma
Motley Fool
Wed, 09/7/11 - 09:49 am
ViroPharma
Gilead
Cubist Pharmaceuticals
Salix
Bullish on Optimer Pharma
Yahoo/Zacks.com
Tue, 08/16/11 - 08:22 am
Optimer
antibiotics
Dificid
Clostridium Difficile
Cubist Pharmaceuticals
ViroPharma
Cubist launches drug trial aimed at hospital-acquired infections
Bizjournals.com
Tue, 08/2/11 - 11:36 am
antibiotics
Cubist Pharmaceuticals
gram negative bacterial infections
CXA-201
Optimer Launches Dificid
Yahoo/Zacks.com
Wed, 07/20/11 - 06:48 pm
Optimer
Dificid
Cubist Pharmaceuticals
Clostridium Difficile
antibiotics
Cubist Pharmaceuticals 2Q11 Total Net Revenues $176.8 Million
Yahoo
Fri, 07/15/11 - 01:04 am
earnings
Cubist Pharmaceuticals
The 15 Most-Watched BioPharma Stocks
Motley Fool
Wed, 07/13/11 - 04:53 pm
MannKind
Celgene
Amarin
Vertex Pharmaceuticals
BioSante
Keryx
Amylin
Regeneron
Immunogen
Cubist Pharmaceuticals
Isis Pharmaceuticals
Sunesis
OPKO Health
SciClone
Cephalon
A Pre-Earnings Look at Cubist Pharma
Seeking Alpha
Mon, 07/11/11 - 09:55 am
earnings
Cubist Pharmaceuticals
Japanese Approval for Merck Products
Yahoo/Zacks.com
Thu, 07/7/11 - 07:40 pm
Japan
Gardasil
Merck
HPV
cervical cancer
Cubicin
Cubist Pharmaceuticals
Merck says Gardasil, Cubicin approved in Japan
Yahoo/AP
Fri, 07/1/11 - 09:47 am
Gardasil
Japan
Merck
Cubicin
Cubist Pharmaceuticals
Cubist might stay clear of Ph3 for antibiotic, analyst says
Fierce Biotech
Fri, 06/17/11 - 12:39 pm
antibiotics
Cubist Pharmaceuticals
Clostridium Difficile
Cubist Pharma rises on speculation about potential sale to Irish drugmaker Shire
Yahoo/AP
Fri, 05/27/11 - 08:53 am
Shire
M&A
Cubist Pharmaceuticals
Drug-Resistant Germs Lure Biotechs to Lead Antibiotics Effort
Bloomberg
Tue, 05/17/11 - 09:51 am
antibiotics
biotech
Dificid
Optimer
Trius Therapeutics
Cubist Pharmaceuticals
Medicines Company
Cubist 1Q profit rises on Cubicin sales
Yahoo/AP
Thu, 04/14/11 - 10:31 pm
Cubist Pharmaceuticals
earnings
Optimer to Co-Market Dificid Drug With Cubist Pharmaceuticals
Bloomberg
Wed, 04/6/11 - 08:18 am
Dificid
Cubist Pharmaceuticals
Optimer
antibiotics
fidaxomicin
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »